# Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure

> **NCT04208581** · PHASE3 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 372 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Chronic Respiratory Failure

## Interventions

- **DRUG:** Yiqi Huoxue Huatan granule
- **DRUG:** Placebo Yiqi Huoxue Huatan granule

## Key facts

- **NCT ID:** NCT04208581
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-08
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2020-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04208581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04208581, "Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04208581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*